Meta Pixel

News and Announcements

Anteo Diagnostics Ltd Acquires DIAsource ImmunoAssays SA & Other Highlights

  • Published July 06, 2016 11:19AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates
6th July 2016, Anteo Diagnostics

Revenues of €14.171M in CY15 growing at greater than 10% per annum
DIAsource provides a strong platform

Other highlights from the past 12 months include:

  • Filed two new patents in battery (energy) space 
  • Appointed new distributors, including Sigma Aldrich
  • Successful trip to Tokyo Battery Expo yielded strong interest with global battery companies
  • Appointed Dr Jef Vangenechten Global CEO and Mr Rolf Sickman to the Board
  • Collaborating with Cook Medical on medical devices
  • Awarded funding for the development of a new rapid blood test for heart attacks in partnership with Atomo Diagnostics

ABOUT ANTEO DIAGNOSTICS

Anteo Diagnostics (ASX: ADO) is a global medical technology company, developing and commercialising products for sale into the lifesciences, in-vitro diagnostics, point of care, medical devices and bioseparations markets.

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now